Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

In the Literature

  • Article

    Anticoagulation and Antiplatelet Therapy in Patients with AF and Atherosclerosis

    April 6, 2026

    CLINICAL QUESTION: In patients with atherosclerotic disease and concurrent atrial fibrillation, does adding antiplatelet therapy to oral anticoagulation improve net clinical outcomes compared with...

  • Article

    Impact of Long-Term Beta-Blocker Therapy on Death and Recurrent MI in Patients with Acute MI with Preserved Ejection Fraction

    April 6, 2026

    CLINICAL QUESTION: Does therapy with a beta-blocker reduce mortality and myocardial infarction (MI) in patients with a recent myocardial infarction with preserved ejection fraction? BACKGROUND: The...

  • Article

    Caffeinated Coffee Consumption Reduces AF Recurrence After Electrical Cardioversion

    April 6, 2026

    CLINICAL QUESTION: What effect does coffee consumption have on atrial fibrillation (AF) after successful electrical cardioversion? BACKGROUND: Coffee is one of the most-consumed beverages, and it...

  • Article

    Bedside Chair Placement Increases Physician Sitting and Patient Satisfaction Without Extending Visit Duration

    April 6, 2026

    CLINICAL QUESTION: Does the simple “nudge” of placing a chair near a patient’s bedside influence how often hospitalist physicians sit during consultations and improve patient...

  • Article

    Comparative Efficacy and Safety of Clopidogrel Versus Aspirin Monotherapy in Patients with Established CAD

    April 6, 2026

    CLINICAL QUESTION: Does monotherapy with clopidogrel reduce the risk of major adverse cardiovascular or cerebrovascular events (MACCE) compared to monotherapy with aspirin in patients with...

  • Article

    Optimal Timing of Anticoagulation Initiation After Ischemic Stroke in Patients with AF

    April 6, 2026

    CLINICAL QUESTION: In patients with atrial fibrillation (AF) and acute ischemic stroke, does early anticoagulation initiation (within four days) improve outcomes compared to delayed...

  • Article

    Optimal Management of Febrile Neutropenia in Oncologic and Oncohematologic Patients

    April 6, 2026

    CLINICAL QUESTION: Is initial empiric antibiotic coverage important in patients with febrile neutropenia? How should the therapeutic strategy be defined? BACKGROUND: Febrile neutropenia is defined...

  • Article

    Low-Dose Glucocorticoids Reduce Mortality in CAP

    April 6, 2026

    CLINICAL QUESTION: Do glucocorticoids reduce mortality in hospitalized adults with community-acquired pneumonia in a resource-limited setting? BACKGROUND: The use of glucocorticoids as adjunctive...

  • Article

    Invasive Versus Conservative Strategy in Older Adults with NSTE-ACS: Fewer Infarctions Without a Mortality Benefit

    April 6, 2026

    CLINICAL QUESTION: In patients aged 70 years or older with non–ST-segment elevation acute coronary syndrome (NSTEACS), does an invasive strategy reduce mortality and cardiovascular events compared...

  • Article

    The Apparent Increase in the Incidence of Early-Onset Cancer in the U.S. Population

    April 6, 2026

    CLINICAL QUESTION: Does the observed rise in cancer rates reflect a true increase in incidence, or is it primarily attributable to heightened diagnostic scrutiny? BACKGROUND: In recent years, the...

1 2 3 … 76Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • Cookie Preferences